|
|
This article has multiple issues. Please help improve it or discuss these issues on the talk page.
|
Embase is an online information source of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug. Through its unique and comprehensive content coverage, frequent updates, and deep drug indexing, Embase enables tracking and precise retrieval of drug adverse events in the published literature. Embase is produced by Elsevier and contains over 25 million records from 1947[1] to the present. Each record is fully indexed and Articles in Press are available for some records and In Process are available for all records, ahead of full indexing. Embase covers over 7,600 biomedical journals from 90 countries and it is available online through a number of database vendors.[2]
See also [edit]
References [edit]
- ^ "Biomedical Answers". Embase. Retrieved 2012-03-04.
- ^ Embase, Elsevier
- Kleijnen, Jos; Knipschild, Paul (1992). "The comprehensiveness of Medline and Embase computer searches". Pharmaceutisch Weekblad Scientific Edition 14 (5): 316–320. doi:10.1007/BF01977620.
- Lefebvre, Carol; Eisinga, Anne; McDonald, Steve; Paul, Nina (2008). "Enhancing access to reports of randomized trials published world-wide - the contribution of EMBASE records to the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library". Emerging Themes in Epidemiology 5 (1): 13. doi:10.1186/1742-7622-5-13.
- Sampson, M (2003). "Should meta-analysts search Embase in addition to Medline?". Journal of Clinical Epidemiology 56 (10): 943–955. doi:10.1016/S0895-4356(03)00110-0.
External links [edit]
